Geneoscopy's ColoSense® Test Included as a Preferred Option in the ACS Colorectal Cancer Screening Guidelines Update
Geneoscopy, a BioGenerator portfolio company, just reached a major milestone. Widely recognized as a gold standard in oncology and public health, the American Cancer Society (ACS) guidelines play a critical role in shaping cancer screening practices nationwide. The addition…
